Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
批准号:
7623633
负责人:
RAJ M LAKSHMAN
金额:
$3.15万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-01 至 2009-04-30
关键词:
4 hydroxynonenalAbstinenceAcetaldehydeAddressAdmission activityAlcohol abuseAlcohol consumptionAlcoholic beverage heavy drinkerAlcoholsAldehydesAnimal ModelAnimalsAntiatherogenicArterial IntimasBiological AssayBloodBrain hemorrhageCalciumCardiacCardiomyopathiesCardiovascular systemCholesterolClinicalCohort StudiesConditionCoronary ArteriosclerosisDataDeveloped CountriesDeveloping CountriesDoseDown-RegulationEdetic AcidEnzymesEpidemiologic StudiesEthanolEventExhibitsFoam CellsFree RadicalsGene ExpressionGenerationsGenesGenetic PolymorphismGenetic TranscriptionGenotypeHandHeavy DrinkingHepaticHigh Density LipoproteinsHigh PrevalenceHumanHypertensionIncidenceIndiumIndividualInvestigationLeadLightLipid PeroxidationLipoprotein BindingLipoproteinsLiverLiver diseasesLow Density Lipoprotein oxidationLow PrevalenceLow-Density LipoproteinsMalondialdehydeMediatingMessenger RNAMetabolicMetabolic DiseasesMolecularMorbidity - disease rateMyocardial InfarctionNorthern BlottingNuclearNumbersOxidantsOxidative StressPathway interactionsPeripheralPersonal SatisfactionPlasmaPlayPopulationPopulation StudyPredispositionProcessProductionProtein IsoformsProteinsQualifyingRattusRegulationRelative (related person)ReportingRiskRoleRun-On AssaysRunningSamplingSerumShapesSystemTestingTimeTissuesUp-RegulationWeekWorkalcohol abstinencealcohol effectalcohol exposureartery occlusionaryldialkylphosphatasebasechronic alcohol ingestiondaydosagedrinkingenzyme activityesterasefeedinghuman studyinsightlight effectsmRNA Stabilitymacrophagemortalityoxidationoxidized low density lipoproteinpreventproblem drinkerprogramsprospectiveprotective effectresearch studyreverse cholesterol transportuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
LDL is oxidized to oxidized LDL (OxLDL) that is rapidly taken up by macropnages leading to coronary artery
disease (CAD). Paraoxonase (PON), a HDL-bound polymorphic enzyme, lowers OxLDL level and thus
prevents CAD.PI hypothesizes that light drinking (13-40 g/day) increases serum PON level and thereby lowers
OxLDL by preventing its formation or by destroying it and thus has a cardioprotective effect, whereas heav^
drinking (>80g/day) has the opposite effects. PI has the following new data to support his hypothesis:! Serunr
PON activity is increased 3.95-fold (p<0.001) in light drinkers, but decreased by 45% (p<0.001) in
drinkers compared to nondrinkers. 2. HDL-PON inhibited LDL oxidation that is preventedby prior incubatior
of HDL with either anti-PON or EDTA. 3. HDL-PON also destroyed OxLDL and inhibited OxLDL uptake b)
macrophages. 4. Hepatic PON mRNA relative to GAPDH mRNA is increased by 59% (p < 0.001) in ligh
alcohol-fed and decreased by 51% (p < 0.001) in heavy alcohol-fed rats compared to controls. Therefore, P
proposes to delineate the action of alcohol in causing diametrically opposite effects on PON and OxLDL status,
Studies in humans: PI will determine serum PON activity and protein in light, heavy and non-drinker;
without liver disease before and after 4- & 8-week abstinence and correlate with plasma oxidizedLDL
status and incidence of CAD by qualified cardiologists. PI will test serum samples from each study group fo
their ability to (i) inhibit LDL oxidation (ii) destroy OxLDL and (iii). prevent OxLDL uptake by macrophages. P
will also genotype PON genes in the study groups to correlate their susceptibility to light and heavy alcoho
drinking. Finally, PI will test whether light or heavy drinking up-regulated or down-regulates PONS allozyme.
Studies in rats: Since PON is expressed only in the liver (except PONS), molecular regulation of P0r>
by alcohol can only be studied in an animal system like rat under well-defined conditions. PI will determinethe
effects of ethanol dosage and duration of exposure on hepatic PON concentration and its mRNA level b}
Western Blot and Northern Blot analyses, respectively. PI will then determine whether ethanol regulates PON
mRNA at transcriptional or post-transcriptional level by Nuclear-run-on and mRNA stability assays. These
investigations are likely to lead to new insights in our understanding of the cardioprotective effects of ligh
drinking and proatherogenic effects of heavy drinking both at clinical and at molecular levels.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD
-
批准号:8854003
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2014
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD
-
批准号:8609964
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2014
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Novel Modulators of Alcohol Induced Metabolic and Liver Injury
-
批准号:8724156
-
项目类别:
-
资助金额:$10.6万
-
财政年份:2013
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8307287
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8504896
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8702054
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8460995
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8203160
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8900880
-
项目类别:
-
资助金额:$45.4万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
BRAIN SOCS3 AND PTP1B-ADIPOSE LEPTIN FEEDBACK AXIS IN ALCOHOLIC HEPATOSTEATOSIS
-
批准号:8144479
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2010
-
负责人:RAJ M LAKSHMAN
-
依托单位:
BRAIN SOCS3 AND PTP1B-ADIPOSE LEPTIN FEEDBACK AXIS IN ALCOHOLIC HEPATOSTEATOSIS
-
批准号:8065693
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2010
-
负责人:RAJ M LAKSHMAN
-
依托单位:
MODULATORS OF ALCOHOLIC LIPIDEMIA & STEATOSIS:KEY ROLE OF SCAVENGER RECEPTOR B I
-
批准号:7926902
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2009
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ACTION OF ALCOHOL/QUERCETIN ON ANTI-ATHEROGENIC FACTOR
-
批准号:7146990
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2006
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ACTION OF ALCOHOL & QUERCETIN ON ANTI-ATHEROGENIC FACTORS & ATHEROGENESIS
-
批准号:7267983
-
项目类别:
-
资助金额:$17.59万
-
财政年份:2006
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6542331
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6917377
-
项目类别:
-
资助金额:$6.28万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6744843
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6890039
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:7057373
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6604221
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
海外基金